"10.1371_journal.pone.0071519","plos one","2013-08-19T00:00:00Z","Daniel Schock-Kusch; Stefania Geraci; Esther Ermeling; Yury Shulhevich; Carsten Sticht; Juergen Hesser; Dzmitry Stsepankou; Sabine Neudecker; Johannes Pill; Roland Schmitt; Anette Melk","Medical Research Centre, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany; Department of Nephrology, Hannover Medical School, Hannover, Germany; Department of Kidney, Liver and Metabolic Diseases, Childrens Hospital, Hannover Medical School, Hannover, Germany; Experimental Radiation Oncology, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany; Mannheim Pharma and Diagnostics GmbH Mannheim; Germany","Conceived and designed the experiments: DSK SG RS AM. Performed the experiments: DSK SG EE. Analyzed the data: DSK CS JH YS DS. Contributed reagents/materials/analysis tools: CS JH YS DS. Wrote the paper: DSK SG SN JP RS AM.","DS-K, JH and JP are inventors on patents and patent applications (WO/2010/020673: Transcutaneous organ function measurement; WO/2001/085799: Fluorescein isothiocyanate (FITC) sinistrin, its production and use) covering this subject, as well as founders of Mannheim Pharma & Diagnostics GmbH (distributor of FITC-sinistrin and the NIC-Kidney devices). Moreover JP is managing director of Mannheim Pharma & Diagnostics GmbH. None of the above mentioned circumstances influenced the work presented in the manuscript submitted. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","08","Daniel Schock-Kusch","DSK",11,TRUE,4,3,5,6,TRUE,TRUE,FALSE,0,NA,FALSE
